ISOPTIN Drug Patent Profile
✉ Email this page to a colleague
When do Isoptin patents expire, and when can generic versions of Isoptin launch?
Isoptin is a drug marketed by Mt Adams and is included in two NDAs.
The generic ingredient in ISOPTIN is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isoptin
A generic version of ISOPTIN was approved as verapamil hydrochloride by EXELA PHARMA on March 30th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOPTIN?
- What are the global sales for ISOPTIN?
- What is Average Wholesale Price for ISOPTIN?
Summary for ISOPTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 10 |
| Patent Applications: | 305 |
| DailyMed Link: | ISOPTIN at DailyMed |
Recent Clinical Trials for ISOPTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assiut University | N/A |
| Assiut University | Early Phase 1 |
| Maastricht University Medical Center | N/A |
US Patents and Regulatory Information for ISOPTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mt Adams | ISOPTIN | verapamil hydrochloride | INJECTABLE;INJECTION | 018485-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mt Adams | ISOPTIN | verapamil hydrochloride | TABLET;ORAL | 018593-002 | Mar 8, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mt Adams | ISOPTIN | verapamil hydrochloride | TABLET;ORAL | 018593-003 | Nov 23, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
